Stay updated on Nivolumab with RT for Head & Neck Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.

Latest updates to the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page
- Check4 days agoChange DetectedCore content updated to Revision: v3.0.2, replacing v3.0.1. The old Revision: v3.0.1 label and the 'Back to Top' link were removed, a minor navigation change.SummaryDifference0.2%
- Check11 days agoChange DetectedThe page has been updated to version 3.0.1, and the section on Melanoma from MedlinePlus Genetics has been removed.SummaryDifference0.4%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new topics related to radiotherapy and immunology. Notably, previous references to certain genetic diseases and specific antineoplastic agents have been removed.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Nivolumab with RT for Head & Neck Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.